查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2151843

血管生成類器官市場規模、佔有率和趨勢分析報告：按產品/服務、血管生成方法、類器官類型、應用、最終用途、地區和細分市場預測（2026-2033 年）

Vascularized Organoids Market Size, Share & Trends Analysis Report By Products & Services, By Vascularization Approach, By Organoid Type, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

血管成形術類器官市場概述

全球血管化類器官市場預計到 2025 年將達到 9,430 萬美元，到 2026 年將成長到 1.235 億美元，到 2033 年將成長到 9.083 億美元，2026 年至 2033 年的複合年成長率為 33.0%。

北美市場領先，預計到 2025 年將佔據 43.0% 的最大銷售佔有率。市場成長的驅動力來自幹細胞技術、3D 生物列印、血管生成技術和類器官培養系統的進步，以及血管化類器官在藥物發現、疾病建模、再生醫學和個人化醫療中日益廣泛的應用。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 產業分析工具

第4章：產品與服務業務分析

  • 血管成形術類器官市場：產品與服務波動分析
  • 試劑盒、試劑、培養基
  • 設備和平台
  • 服務

第5章：血管生成技術的商業分析

  • 血管成形術類器官市場：血管成形術技術變革分析
  • 靜態體外方法
  • 灌注/微流體系統
  • 體內/移植方法
  • 生物列印構建體

第6章：類器官類型的商業分析

  • 血管成形術類器官市場：按類器官類型分類的波動分析
  • 肝
  • 腦
  • 心
  • 腎
  • 肺
  • 其他

第7章 應用業務分析

  • 血管化類器官市場：按應用領域分類的趨勢分析
  • 藥物發現
  • 疾病建模
  • 毒性測試
  • Snow/個人化醫療
  • 再生醫學與移植

第8章 依最終用途進行業務分析

  • 血管化類器官市場：依最終用途分類的趨勢分析
  • 製藥和生物技術公司
  • 學術研究機構
  • CRO

第9章：區域商業分析

  • 血管成形術類器官市場佔有率：按地區分類，2025 年和 2033 年
  • 北美洲
    • 2021-2033年北美血管成形術類器官市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2021-2033年歐洲血管化類器官市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2021-2033年亞太地區血管醫學類器官市場
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2021-2033年拉丁美洲血管成形術類器官市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東及非洲血管成形術類器官市場
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第10章 競爭格局

  • 公司分類
  • 企業市場占有率及定位分析，2025年
  • 策略規劃
  • 公司簡介列表
    • Thermo Fisher Scientific Inc.
    • Corning Incorporated
    • STEMCELL Technologies
    • Emulate, Inc.
    • CN Bio Innovations
    • MIMETAS
    • InSphero AG
    • TissUse GmbH
    • AIM Biotech
    • Vivodyne
Product Code: GVR-4-68041-051-2

Vascularized Organoids Market Summary

The global vascularized organoids market size was valued at USD 94.3 million in 2025 and is projected to grow from USD 123.5 million in 2026 to USD 908.3 million by 2033, at a CAGR of 33.0% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 43.0% in 2025. Market growth is driven by increasing adoption of vascularized organoids in drug discovery, disease modeling, regenerative medicine, and personalized medicine, alongside advancements in stem cell technologies, 3D bioprinting, vascularization techniques, and organoid culture systems.

Global Vascularized Organoids Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global vascularized organoids market on the basis of products & services, vascularization approach, organoid type, application, end-use, and region:

  • Products & Services Outlook (Revenue, USD Million, 2021 - 2033)
  • Kits, Reagents & Media
  • Instruments & Platforms
  • Services
  • Vascularization Approach Outlook (Revenue, USD Million, 2021 - 2033)
  • Static In Vitro Methods
  • Perfused / Microfluidic Systems
  • In Vivo / Transplantation-Based Methods
  • Bioprinted Constructs
  • Organoid Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Liver
  • Brain
  • Cardiac
  • Kidney
  • Lung
  • Other
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery
  • Disease Modeling
  • Toxicity Testing
  • Precision / Personalized Medicine
  • Regenerative Medicine & Transplantation
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • CROs
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Products & Services Segment
      • 1.1.1.2. Vascularization Approach Segment
      • 1.1.1.3. Organoid Type Segment
      • 1.1.1.4. Application Segment
      • 1.1.1.5. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. List of Secondary Sources
    • 1.9.3. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Prevalence of Chronic Diseases and Cancer
      • 3.2.1.2. Growing Adoption in Drug Discovery and Toxicity Testing
      • 3.2.1.3. Advancements in Stem Cell And 3D Cell Culture Technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost of Organoid Development and Maintenance
      • 3.2.2.2. Complexity of Vascularization and Organoid Culture
    • 3.2.3. Market Opportunities Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Economic landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Products & Services Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Vascularized Organoids Market: Products & Services Movement Analysis
  • 4.3. Kits, Reagents & Media
    • 4.3.1. Kits, Reagents & Media Market, 2021 - 2033 (USD Million)
  • 4.4. Instruments & Platforms
    • 4.4.1. Instruments & Platforms Market, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market, 2021 - 2033 (USD Million)

Chapter 5. Vascularization Approach Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Vascularized Organoids Market: Vascularization Approach Movement Analysis
  • 5.3. Static In Vitro Methods
    • 5.3.1. Static In Vitro Methods Market, 2021 - 2033 (USD Million)
  • 5.4. Perfused / Microfluidic Systems
    • 5.4.1. Perfused / Microfluidic Systems Market, 2021 - 2033 (USD Million)
  • 5.5. In Vivo / Transplantation-Based Methods
    • 5.5.1. In Vivo / Transplantation-Based Methods Market, 2021 - 2033 (USD Million)
  • 5.6. Bioprinted Constructs
    • 5.6.1. Bioprinted Constructs Market, 2021 - 2033 (USD Million)

Chapter 6. Organoid Type Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Vascularized Organoids Market: Organoid Type Movement Analysis
  • 6.3. Liver
    • 6.3.1. Liver Market, 2021 - 2033 (USD Million)
  • 6.4. Brain
    • 6.4.1. Brain Market, 2021 - 2033 (USD Million)
  • 6.5. Cardiac
    • 6.5.1. Cardiac Market, 2021 - 2033 (USD Million)
  • 6.6. Kidney
    • 6.6.1. Kidney Market, 2021 - 2033 (USD Million)
  • 6.7. Lung
    • 6.7.1. Lung Market, 2021 - 2033 (USD Million)
  • 6.8. Other
    • 6.8.1. Other Market, 2021 - 2033 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Vascularized Organoids Market: Application Movement Analysis
  • 7.3. Drug Discovery
    • 7.3.1. Drug Discovery Market, 2021 - 2033 (USD Million)
  • 7.4. Disease Modeling
    • 7.4.1. Disease Modeling Market, 2021 - 2033 (USD Million)
  • 7.5. Toxicity Testing
    • 7.5.1. Toxicity Testing Market, 2021 - 2033 (USD Million)
  • 7.6. Precision / Personalized Medicine
    • 7.6.1. Precision / Personalized Medicine Market, 2021 - 2033 (USD Million)
  • 7.7. Regenerative Medicine & Transplantation
    • 7.7.1. Regenerative Medicine & Transplantation Market, 2021 - 2033 (USD Million)

Chapter 8. End Use Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. Vascularized Organoids Market: End Use Movement Analysis
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 8.4. Academic & Research Institutes
    • 8.4.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
  • 8.5. CROs
    • 8.5.1. CROs Market, 2021 - 2033 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Vascularized Organoids Market Share By Region, 2025 & 2033
  • 9.2. North America
    • 9.2.1. North America Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Competitive Scenario
      • 9.2.2.3. Regulatory Framework
      • 9.2.2.4. U.S. Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Competitive Scenario
      • 9.2.3.3. Regulatory Framework
      • 9.2.3.4. Canada Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Competitive Scenario
      • 9.2.4.3. Regulatory Framework
      • 9.2.4.4. Mexico Vascularized Organoids Market, 2021 - 2033 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. UK Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Germany Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. France Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Competitive Scenario
      • 9.3.5.3. Regulatory Framework
      • 9.3.5.4. Italy Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Competitive Scenario
      • 9.3.6.3. Regulatory Framework
      • 9.3.6.4. Spain Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Competitive Scenario
      • 9.3.7.3. Regulatory Framework
      • 9.3.7.4. Denmark Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Competitive Scenario
      • 9.3.8.3. Regulatory Framework
      • 9.3.8.4. Sweden Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Competitive Scenario
      • 9.3.9.3. Regulatory Framework
      • 9.3.9.4. Norway Vascularized Organoids Market, 2021 - 2033 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. Japan Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. China Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. India Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Australia Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.4.6. Thailand
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Thailand Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.4.7. South Korea
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. South Korea Vascularized Organoids Market, 2021 - 2033 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Brazil Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. Argentina Vascularized Organoids Market, 2021 - 2033 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. South Africa Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Saudi Arabia Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. UAE Vascularized Organoids Market, 2021 - 2033 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Competitive Scenario
      • 9.6.5.3. Regulatory Framework
      • 9.6.5.4. Kuwait Vascularized Organoids Market, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Company Market Share/ Position Analysis, 2025
  • 10.3. Strategy Mapping
  • 10.4. Company Profiles/Listing
    • 10.4.1. Thermo Fisher Scientific Inc.
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Corning Incorporated
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. STEMCELL Technologies
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Emulate, Inc.
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. CN Bio Innovations
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. MIMETAS
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. InSphero AG
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. TissUse GmbH
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. AIM Biotech
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Vivodyne
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 4 Global vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 5 Global vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 6 Global vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 7 Global vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 8 Global vascularized organoids market, by region, 2021 - 2033 (USD Million)
  • Table 9 North America vascularized organoids market, by country, 2021 - 2033 (USD Million)
  • Table 10 North America vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 11 North America vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 12 North America vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 13 North America vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 14 North America vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 15 U.S. vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 16 U.S. vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 17 U.S. vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 18 U.S. vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 19 U.S. vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Canada vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 21 Canada vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 22 Canada vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 23 Canada vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 24 Canada vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Mexico vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 26 Mexico vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 27 Mexico vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 28 Mexico vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 29 Mexico vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 30 Europe vascularized organoids market, by country, 2021 - 2033 (USD Million)
  • Table 31 Europe vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 32 Europe vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 33 Europe vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 34 Europe vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 35 Europe vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 36 UK vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 37 UK vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 38 UK vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 39 UK vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 40 UK vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Germany vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 42 Germany vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 43 Germany vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 44 Germany vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 45 Germany vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 46 France vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 47 France vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 48 France vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 49 France vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 50 France vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 51 Italy vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 52 Italy vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 53 Italy vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 54 Italy vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 55 Italy vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 56 Spain vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 57 Spain vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 58 Spain vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 59 Spain vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 60 Spain vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Denmark vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 62 Denmark vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 63 Denmark vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 64 Denmark vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 65 Denmark vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Sweden vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 67 Sweden vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 68 Sweden vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 69 Sweden vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 70 Sweden vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 71 Norway vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 72 Norway vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 73 Norway vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 74 Norway vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 75 Norway vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific vascularized organoids market, by country, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 81 Asia Pacific vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Japan vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 83 Japan vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 84 Japan vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 85 Japan vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 86 Japan vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 87 China vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 88 China vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 89 China vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 90 China vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 91 China vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 92 India vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 93 India vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 94 India vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 95 India vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 96 India vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 97 Australia vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 98 Australia vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 99 Australia vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 100 Australia vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 101 Australia vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 102 Thailand vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 103 Thailand vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 104 Thailand vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 105 Thailand vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 106 Thailand vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 107 South Korea vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 108 South Korea vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 109 South Korea vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 110 South Korea vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 111 South Korea vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 112 Latin America vascularized organoids market, by country, 2021 - 2033 (USD Million)
  • Table 113 Latin America vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 114 Latin America vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 115 Latin America vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 116 Latin America vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 117 Latin America vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 118 Brazil vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 119 Brazil vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 120 Brazil vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 121 Brazil vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 122 Brazil vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 123 Argentina vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 124 Argentina vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 125 Argentina vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 126 Argentina vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 127 Argentina vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 128 Middle East & Africa vascularized organoids market, by country, 2021 - 2033 (USD Million)
  • Table 129 Middle East & Africa vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 130 Middle East & Africa vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 131 Middle East & Africa vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 132 Middle East & Africa vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 133 Middle East & Africa vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 134 South Africa vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 135 South Africa vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 136 South Africa vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 137 South Africa vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 138 South Africa vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 143 Saudi Arabia vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 144 UAE vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 145 UAE vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 146 UAE vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 147 UAE vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 148 UAE vascularized organoids market, by end use, 2021 - 2033 (USD Million)
  • Table 149 Kuwait vascularized organoids market, by products & services, 2021 - 2033 (USD Million)
  • Table 150 Kuwait vascularized organoids market, by vascularization approach, 2021 - 2033 (USD Million)
  • Table 151 Kuwait vascularized organoids market, by organoid type, 2021 - 2033 (USD Million)
  • Table 152 Kuwait vascularized organoids market, by application, 2021 - 2033 (USD Million)
  • Table 153 Kuwait vascularized organoids market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Vascularized organoids market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Vascularized organoids market driver analysis
  • Fig. 12 Vascularized organoids market restraint analysis
  • Fig. 13 Vascularized organoids market: Porter's five forces analysis
  • Fig. 14 Vascularized organoids market: PESTLE analysis
  • Fig. 15 Vascularized organoids market: products & services outlook and key takeaways
  • Fig. 16 Vascularized organoids market: products & services market share analysis
  • Fig. 17 Kits, reagents & media market, 2021 - 2033 (USD Million)
  • Fig. 18 Instruments & platforms market, 2021 - 2033 (USD Million)
  • Fig. 19 Services market, 2021 - 2033 (USD Million)
  • Fig. 20 Vascularized organoids market: vascularization approach outlook and key takeaways
  • Fig. 21 Vascularized organoids market: vascularization approach market share analysis
  • Fig. 22 Static in vitro methods market, 2021 - 2033 (USD Million)
  • Fig. 23 Perfused / microfluidic systems market, 2021 - 2033 (USD Million)
  • Fig. 24 In vivo / transplantation-based methods market, 2021 - 2033 (USD Million)
  • Fig. 25 Bioprinted constructs market, 2021 - 2033 (USD Million)
  • Fig. 26 Vascularized organoids market: organoid type outlook and key takeaways
  • Fig. 27 Vascularized organoids market: organoid type market share analysis
  • Fig. 28 Liver market, 2021 - 2033 (USD Million)
  • Fig. 29 Brain market, 2021 - 2033 (USD Million)
  • Fig. 30 Cardiac market, 2021 - 2033 (USD Million)
  • Fig. 31 Kidney market, 2021 - 2033 (USD Million)
  • Fig. 32 Lung market, 2021 - 2033 (USD Million)
  • Fig. 33 Other organoid types market, 2021 - 2033 (USD Million)
  • Fig. 34 Vascularized organoids market: application outlook and key takeaways
  • Fig. 35 Vascularized organoids market: application market share analysis
  • Fig. 36 Drug discovery market, 2021 - 2033 (USD Million)
  • Fig. 37 Disease modeling market, 2021 - 2033 (USD Million)
  • Fig. 38 Toxicity testing market, 2021 - 2033 (USD Million)
  • Fig. 39 Precision / personalized medicine market, 2021 - 2033 (USD Million)
  • Fig. 40 Regenerative medicine & transplantation market, 2021 - 2033 (USD Million)
  • Fig. 41 Vascularized organoids market: end use outlook and key takeaways
  • Fig. 42 Vascularized organoids market: end use market share analysis
  • Fig. 43 Pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 44 Academic & research institutes market, 2021 - 2033 (USD Million)
  • Fig. 45 CROs market, 2021 - 2033 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 North America vascularized organoids market, by country, 2021 -2033 (USD Million)
  • Fig. 48 U.S. vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 49 Canada vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 50 Mexico vascularized organoids market, 2021 - 2033, (USD Million)
  • Fig. 51 Europe vascularized organoids market, by country, 2021 -2033 (USD Million)
  • Fig. 52 UK vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 53 Germany vascularized organoids market, 2021 - 2033, (USD Million)
  • Fig. 54 France vascularized organoids market, 2021 - 2033, (USD Million)
  • Fig. 55 Italy vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 56 Spain vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 57 Denmark vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 59 Norway vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 60 Asia-Pacific vascularized organoids market, by country, 2021 -2033 (USD Million)
  • Fig. 61 Japan vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 62 China vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 63 India vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 64 Australia vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 65 Thailand vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 67 Latin America vascularized organoids market, by country, 2021 -2033 (USD Million)
  • Fig. 68 Brazil vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 69 Argentina vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 70 MEA vascularized organoids market, by country, 2021 -2033 (USD Million)
  • Fig. 71 South Africa vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 72 Saudi Arabia vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 73 UAE vascularized organoids market, 2021 - 2033 (USD Million)
  • Fig. 74 Kuwait vascularized organoids market, 2021 - 2033 (USD Million)